2 Undervalued Stocks We Like
Our analysts are excited about these names.
Today we're looking at two overlooked narrow-moat stocks.
DuPont (DD) is undervalued as investors are overly concerned about the company's long-term earnings power, elevated debt levels, and future liabilities related to the company's former PFAS operations. However, we see a bright long-term future for the company. While DuPont's transportation business has seen its profits sharply decline in the first half of 2020, we expect it will fully rebound as global auto builds recover. Longer term, we see growth coming from greater electric vehicle and hybrid adoption, as DuPont generates around 50% more revenue per vehicle on an EV or hybrid than for an internal combustion engine vehicle. We also see long-term growth in the electronics business from the adoption of 5G and in the safety and construction business from U.S. housing starts growth. Although DuPont carries elevated leverage as a result of the DowDuPont spin-off, the company should quickly improve its balance sheet health following the sale of its nutrition and biosciences business. The transaction features a $7.3 billion dividend payment to DuPont, which it will mostly use to reduce debt. Finally, we view PFAS liabilities as a minor concern for DuPont.
Morningstar does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.